Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition

New insights into the mechanisms of organ-specific breast cancer metastasis

(2012) Girieca Lorusso et al.   SEMINARS IN CANCER BIOLOGY

Death causes in breast cancer patients

(2011) M. Riihimaki et al.   ANNALS OF ONCOLOGY

Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways

(2011) Eun-Jung Park et al.   BIOCHEMICAL PHARMACOLOGY

Apoptosis Inhibitor ARC Promotes Breast Tumorigenesis, Metastasis, and Chemoresistance

(2011) C. M. Medina-Ramirez et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-κB pathway in mice

(2011) Vijayasree V. Giridharan et al.   FREE RADICAL RESEARCH

Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death

(2011) Hao Wu et al.   JOURNAL OF PATHOLOGY

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

(2011) Yang Xu et al.   PLoS One

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cancer metastasis as a therapeutic target

(2010) Jonathan Sleeman et al.   EUROPEAN JOURNAL OF CANCER

Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion

(2010) Wei Ding et al.   HEPATOLOGY

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

(2010) Li Ma et al.   NATURE BIOTECHNOLOGY

Molecular mechanisms of metastasis in breast cancer—clinical applications

(2010) Michal Mego et al.   Nature Reviews Clinical Oncology

Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

(2010) Abhik Bandyopadhyay et al.   PLoS One

Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer

(2009) Michael S. Sabel et al.   BREAST CANCER RESEARCH AND TREATMENT

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease

(2009) Hervé Acloque et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response

(2009) H. Nishida et al.   NUCLEIC ACIDS RESEARCH

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae

(2008) Min Huang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-  in mammary epithelial cells via a MMP-dependent mechanism

(2008) Y.-H. Lee et al.   CARCINOGENESIS

Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma

(2008) Shuli Man et al.   CLINICAL & EXPERIMENTAL METASTASIS

The Wnt-5a-Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility

(2008) A. Safholm et al.   CLINICAL CANCER RESEARCH